An in vivo tracking system to investigate the migration of bone marrow stem cells in an osteochondral defect model  by Lee, J. et al.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S52under Good Laboratory Practise (GLP) conditions, after local intra-
articular (IA) injection in mice.
Methods: Clinical grade ASC were isolated from subcutaneous
abdominal fat, expanded in a-MEM medium with 10% platelet lysate
and used at passage 1. ASC were injected either IA (106 cells/knee joint)
or systemically (IV) via the tail vein (106 cells) of SCID mice. At different
time points (day 11, 28, 90 186), 10 mice were euthanasized and several
organs/tissues recovered. After DNA extraction, qPCR was performed
using primers speciﬁc for human Alu or murine actine sequences.
Results: Quantiﬁcation of hASC engraftment was performed through
detection of human-speciﬁc Alu sequences and normalization using
murine actine sequences on DNA extracted from 14 different organs or
tissues. Using serial ten-fold dilutions of hASCs in murine MSCs, a linear
correlation curve between the number of ASC and Alu signal was
established. This curve was comparable between different cell samples
and the detection limit was 0.005% hASCs. After IA injection, hASCs
were detected in 10/10 mice at the different time points. They were in
the joint in more than 90% of mice for the ﬁrst 3 months and were still
observed in 60% of the mice after 6 months. At day 11 and 28,
approximately 15% of the injected cells were recovered in various
organs. Cells were predominantly observed in the knee joints, bone
marrow and fat. After 3 and 6 months, 1.5-4% of infused hASC were still
detected in the joint, bone marrow, fat and muscle. After systemic
injection, hASC were detected in 5 and 4/12 mice in one or two organs
at day 11 and 28, respectively. Only 1.4 and 0.8% of the total infused cells
were detected predominantly in lung, intestine, stomach, liver and
brain.
Conclusions: Contrary to a systemic route, the IA injection of hASC
allowed their survival on the long-term. Cells were predominantly
localized at the site of injection but also, in the stem cell reservoirs, bone
marrow and fat tissue.
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INHIBITORY EFFECT OF MIR-29A ON THE CHONDROGENIC
DIFFERENTIATION OF MESENCHYMAL STEM CELLS
D. Guérit, Jr., D. Philipot, Jr., J.-M. Brondello, Sr., P. Chuchana, Sr.,
C. Jorgensen, Sr., D. Noël, Sr.. Inserm U844, Montpellier, France
Purpose: Mesenchymal stem or stromal cells (MSC) are multipotent
cells that can differentiate into different lineages, particularly osteo-
blasts and chondrocytes. The differentiation process of MSC is regulated
by various molecules among which Sox9 and Runx2 are key tran-
scription factors leading, respectively to chondrogenesis or osteo-
genesis. Recently, a new class of regulating factors, namely microRNAs
(miRNAs), has been shown to be important for differentiation processes
but few miRNAs have been shown to regulate chondrogenesis. The
objective of this study is therefore to identify miRNAs involved in the
chondrogenic differentiation of MSC.
Methods: MiRNA arrays have been done using RNA samples of MSC
(day 0) and MSC-derived pre-chondrocytes (day 3). Analysis of miRNAs,
their putative targets and of transcription factors putatively binding to
their promoter regions was performed using several prediction soft-
wares, in particular Targetscan. Pre-miRs and antagomiRs were trans-
fected in MSC twice (day -4 and -1) using oligofectamine and
chondrogenic differentiation was induced by culture of MSC in micro-
pellets in inductive medium for 21 days. Expression of chondrocyte
markers was performed by RT-qPCR.
Results: Analysis of results from the miRNA arrays together with those
from DNA arrays already available in our laboratory indicated that
a little number of transcription factors was theoretically able to regulate
the majority of the miRNAs that were modulated at day 3 of chondro-
genesis. Among the transcription factors, Sox9 and YY1 can putatively
bind to the promoter region of miR-29. Using real-time RT-PCR, we
observed that the expression level of miR-29 progressively and highly
decreases during the chondrogenic differentiation. Transfection of Sox9
or YY1 in the Stro-1A MSC cell line signiﬁcantly reduced the expression
of miR-29, while transfection of both factors totally abolished its
expression. The effect of gain- and loss-of-function of miR-29 during the
chondrogenic differentiation of MSCs by transfecting pre-miRs or
antago-miRs conﬁrmed the role of miR-29 during chondrogenesis.
Conclusions: Our preliminary data show that, during chondrogenesis,
miR-29 expression is down-regulated, probably through the interaction
of Sox9 and YY1 on the miR promoter region. Because miR-29 has been
described to regulate different targets (DKK1, sFRP2, Kremen2 and
CDK6 whose expression decreases during differentiation), futureexperiments will investigate whether these target genes are modulated
by miR-29.
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MIGRATION POTENTIAL OF MESENCHYMAL STEM CELLS DERIVED
FROM OSTEOARTHRITIC PATIENTS AND THEIR SUITABILITY FOR IN
SITU TISSUE REPAIR
T. Dehne, K. Gulich, T. Häupl, M. Sittinger, J. Ringe. Charite -
Univ.etsmedizin Berlin, Berlin, Germany
Purpose: In situ tissue engineering based on factor-guided recruitment
of mesenchymal stem cells (MSC) is suggested as promising approach
for the treatment of joint cartilage and underlying bone lesions of
patients with osteoarthritis (OA). First strategies to treat focal cartilage
defects have reached clinical level, but focusing on OA, fundamental
studies on feasibility are necessary. The aim of our study was to
compare the chemokine-dependent migration potential and molecular
changes during migration of MSC derived from OA patients and normal
donors.
Methods: MSC were isolated from femoral heads derived from end-
stage OA patients. The chemokine receptor proﬁle of culture expanded
MSC was analyzed on the gene expression level (PCR, Affymetrix
microarray) and by immunohistochemistry. A 96-well plate chemotaxis
assay was used to investigate the migratory response to potent che-
mokines known from normal donor MSC. The chemokines leading to
the most pronounced migration response were further investigated.
The intra- and extracellular expression of chemokine receptors of these
chemokines was quantiﬁed by FACS analysis. Transcriptomic response
to chemokine stimulation of OA MSC was analyzed on the global
molecular level by microarray analysis. The results were compared with
normal donor data.
Results: On the gene expression level, all OA MSC presented the che-
mokine receptors CCR1, CCR3, CCR5-11, XCR1-6 and CXCR1. Immuno-
histochemistry conﬁrmed the results for CCR1, CCR6, CCR7, CCR9 and
CXCR2-6, Donor-dependent results were obtained for CCR5 and CXCR1.
MSC from OA donors showed a dose-dependent migration towards
chemokines CCL2 (MCP1), CCL25 (TECK), CXCL12 (SDF1-alpha) and
CXCL8 (IL8). The strongest migration was measured after the use of
TECK in a concentration of 1000 nM. The corresponding receptor CCR9
was detected intra- and extracellularly by ﬂow cytometry. During
exposition with TECK, alterations on gene expression were detected
involving genes of pathways related to homing of bone marrow cells
(CXCL2, -3, PDE4B), cytoskeletal and membrane reorganization (CXCL8,
IGFBP1) and cell movement (CXCL6, PTGS2, TGM2).
Conclusions: MSC from OA donors present distinct chemokine recep-
tors and migrate towards potent chemokines. This is consistent with
available data of normal donor MSC. Gene expression analysis indicated
the activation of pathways involved in the initiation of chemotaxis and
following migration. The Results proof, that MSC from OA patients fulﬁl
the basic requirements for in situ tissue engineering. In accordancewith
experiences from normal donor MSC, TECK may be also a promising
factor for the in situ recruitment of MSC from OA patients.
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AN IN VIVO TRACKING SYSTEM TO INVESTIGATE THE MIGRATION OF
BONE MARROW STEM CELLS IN AN OSTEOCHONDRAL DEFECT
MODEL
J. Lee 1, B.-S. Kim 2, H. Lee 3, G.-I. Im 1. 1Dongguk Univ. Ilsan Hosp.,
Goyang, KOREA, REPUBLIC OF; 2 Seoul Natl. Univ., Seoul, KOREA,
Republic of Korea; 3KAIST, Daejeon, Republic of Korea
Purpose: To develop an in vivo system tomonitor themigration of bone
marrow-derived MSCs (BMSCs) in an osteochondral defect model.
Methods: Chemotaxis assays were performed in a Boyden chamber to
determine the most effective chemotactic factor. For in vivo study,
BMSCs were labeled with ﬂuorescent nanoparticles and injected into
the marrow cavity of nude rats through osteochondral defects created
in the distal femur. The defect was sealed with HCF (heparin-conjugated
ﬁbrin) or PDGF (platelet-derived growth factor)-AA-loaded HCF to
induce the migration of BMSCs. The in vivo ﬂuorescence was monitored
for 21 days and the osteochondral defect was evaluatedmacroscopically
and histologically after the period.
Results: The in vitro studies conﬁrmed that PDGF-AA had the most
potent chemotactic effect of the factors tested, and possessed the
greatest number of receptors in BMSCs. In the HCF-only group, the
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within 3 days after the injection. In the PDGF-AA-loaded HCF group, the
labeled cells moved time-dependently for 14 days toward the osteo-
chondral defect. HCF-PDGF in low dose (8.5 ng/ml) was more effective
than HCF-PDGF in high dose (17 ng/ml) in recruiting the BMSCs to the
osteochondral defect. The defects treated with PDGF and TGF-b1-loaded HCF showed excellent cartilage repair compared with other
groups. Further studies conﬁrmed that this in vivo osteochondral
BMSCs tracking system (IOBTS) worked for other chemoattractants
(CCL-2 and PDGF-BB).
Conclusions: IOBTS can be a very useful tool for examining the effect of
growth factors or chemokines on BMSC migration and cartilage repair.
